BioMed Realty accepts tenders for $61.27 million 4.5% exchangeables

By Jennifer Chiou

New York, Dec. 9 - BioMed Realty Trust, Inc.'s operating partnership, BioMed Realty, LP, said it accepted tenders from holders of $61.27 million, or about 57%, of its $107.42 million of 4.5% exchangeable senior notes due 2026.

The purchase price was par plus accrued interest up to but excluding the date of purchase, amounting to a total consideration of $61,806,113.

The offer expired at midnight ET on Dec. 8. It began on Nov. 9.

BioMed already said it expected to fund the purchase of the notes by drawing on its unsecured line of credit. The tendered securities will be canceled.

Credit Suisse Securities (USA) LLC (800 820-1653 or 212 538-1862) was the dealer manager for the tender offer, and D.F. King & Co., Inc. (800 431-9645 or, for banks and brokers, 212 269-5550) was the information agent.

BioMed Realty is a San Diego-based real estate investment trust focused on providing real estate to the life science industry.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.